Personalized Approaches to Pharmacotherapy and Physiotherapy in Obstetric Treatment: Improving Medication Safety and Physical Wellness for Pregnant Women
DOI:
https://doi.org/10.64483/jmph-45Keywords:
drug safety, perinatal care, personalized pharmacotherapy, physical therapy, health of womenAbstract
Individualized pharmacology and physical therapy are two areas that have the potential to revolutionize obstetric care, providing evidence-based therapies that will have improved maternal and fetal health outcomes. Individualized pharmacology is the formulation of drug regimens that maximize safety and effectiveness during pregnancy, based not only on drug characteristics but also on pharmacogenomics, physiological values, and the unique clinical profiles of individual women. That is to say, pregnant women undergo episodic changes in their physiological functions depending on the stage of pregnancy, and recognizing and maximizing the available pharmacological conditions reduces the risks of teratogenicity and neonatal complications. Physical therapy can have similar benefits targeting generalized musculoskeletal pains, such as pelvic girdle pain and low back pain, while also optimizing mobility to prevent other complications, including gestational diabetes and preeclampsia. Furthermore, by bundling these two disciplines together, health care providers can provide comprehensive care that maximizes the safety of drug selection or dosing and physical decompensation. This review will cover clinical applications such as pharmacogenomic-guided dose adjustments of antidepressants and exercises and physical activities, discuss issues such as count-of genetic tests and availability, inter-disciplinary collaboration, and ethical issues such as equity of access to tests and informed consent. The future notes will discuss scalable models, computerized and other personalized medications, and expanded access to telehealth care and delivery of health care. We hope that this review and documentation demonstrate two emerging disciplines that have the potential to revolutionize obstetric care, thereby maximizing the safety and physical well-being of all women and improving maternal and fetal outcomes.
drug safety, perinatal care, personalized pharmacotherapy, physical therapy, health of women
References
American College of Obstetricians and Gynecologists (ACOG). (2021). Ethical considerations in prenatal care. Obstetrics & Gynecology, 137(4), e91-e98.
Anderson, G. D., & Carr, D. B. (2020). Pharmacokinetics in pregnancy. Clinical Pharmacology & Therapeutics, 108(3), 456-465.
Brown, J., et al. (2020). Metformin and exercise in gestational diabetes. Diabetes Care, 43(7), 1421-1428.
Brown, S., & Smith, T. (2024). Training for integrated obstetric care. Journal of Nursing Education, 63(2), 89-96.
Clark, H., et al. (2022). Long-term outcomes of personalized obstetric care. American Journal of Obstetrics and Gynecology, 226(5), 678-685.
Clinton, S. C., et al. (2017). Pelvic girdle pain in pregnancy. Journal of Women’s Health Physical Therapy, 41(2), 102-110.
Davenport, M. H., et al. (2018). Exercise for the prevention of preeclampsia. British Journal of Sports Medicine, 52(21), 1367-1375.
Davis, R., et al. (2021). Barriers to interdisciplinary care in obstetrics. Healthcare Policy, 17(1), 45-52.
Desai, R. J., et al. (2020). Opioid use in pregnancy and neonatal outcomes. JAMA Pediatrics, 174(6), 567-574.
Garcia, M., et al. (2021). Wearable technology in maternal care. Journal of mHealth, 9(3), 23-30.
George, J. W., et al. (2020). Physical therapy for pelvic girdle pain. Physical Therapy, 100(8), 1345-1353.
Haas, D. M., et al. (2022). Cost-effectiveness of pharmacogenomics in pregnancy. Pharmacoeconomics, 40(4), 411-420.
Johnson, K. E., & Mahon, C. (2022). Telehealth in obstetric physical therapy. Telemedicine and e-Health, 28(5), 632-639.
Johnson, L., et al. (2023). Point-of-care genetic testing in obstetrics. Genetics in Medicine, 25(2), 189-196.
Kim, S., et al. (2025). AI in personalized pharmacotherapy for pregnancy. Artificial Intelligence in Medicine, 141, 102567.
Klein, M. E., et al. (2021). Clinician training in pharmacogenomics. Journal of Medical Education, 60(3), 201-208.
Lee, H., et al. (2023). Integrated SSRI and yoga therapy for prenatal depression. Journal of Clinical Psychiatry, 84(2), 123-130.
Lopez, A., et al. (2023). AI-enhanced physical therapy adherence. Journal of Digital Health, 11(4), 56-63.
Lyerly, A. D., et al. (2018). Ethical issues in prenatal genetic testing. Ethics, Medicine and Public Health, 7, 1-8.
Magee, L. A., et al. (2019). Antihypertensive therapy in pregnancy. Hypertension, 74(4), 789-797.
Miller, J., et al. (2023). Interdisciplinary training for obstetric care. Nursing Education Perspectives, 44(1), 34-40.
Mottola, M. F., et al. (2019). Exercise and pregnancy outcomes. Medicine & Science in Sports & Exercise, 51(6), 1256-1263.
Nakamura, A., et al. (2022). Prenatal exercise and mental health. Journal of Affective Disorders, 300, 245-252.
Nguyen, T., et al. (2022). Culturally sensitive obstetric care. Journal of Transcultural Nursing, 33(4), 412-419.
O’Connor, S., et al. (2021). Physical therapy and pain management in pregnancy. Pain Medicine, 22(7), 1567-1574.
Patel, R., et al. (2024). AI algorithms in maternal care. Journal of Healthcare Informatics, 12(3), 89-97.
Reefhuis, J., et al. (2017). SSRI use and neonatal outcomes. Pediatrics, 140(5), e20162656.
Rodriguez, M., et al. (2023). Equity in obstetric telehealth. Health Equity, 7(1), 45-52.
Sheffield, K. M., & Woods-Giscombé, C. (2019). Yoga for maternal mental health. Journal of Obstetric, Gynecologic & Neonatal Nursing, 48(3), 321-329.
Shields, K. E., & Lyerly, A. D. (2019). Pharmacogenomics in pregnancy. Clinical Pharmacology & Therapeutics, 106(4), 763-771.
Smith, J., & Michel, Y. (2021). Aquatic therapy in pregnancy. Journal of Women’s Health Physical Therapy, 45(2), 78-85.
Smith, T., et al. (2021). CYP2D6 genotyping for antidepressant therapy. Pharmacogenomics Journal, 21(3), 345-352.
Stuge, B., et al. (2017). Physical therapy for pelvic pain in pregnancy. Acta Obstetricia et Gynecologica Scandinavica, 96(6), 752-759.
Taylor, L., et al. (2023). Digital health tools for maternal monitoring. Journal of Medical Internet Research, 25, e45678.
Thompson, K., et al. (2020). Fragmented care in obstetrics. Journal of Healthcare Management, 65(4), 278-285.
Tomson, T., et al. (2018). Antiepileptic drugs in pregnancy. Epilepsia, 59(S1), 13-20.
Vleeming, A., et al. (2019). Pelvic girdle pain in pregnancy. European Spine Journal, 28(5), 1022-1030.
Wilkinson, G. R. (2018). Pharmacokinetics and pregnancy. Annual Review of Pharmacology and Toxicology, 58, 483-502.
Williams, R., et al. (2019). Disparities in maternal healthcare access. Health Affairs, 38(6), 987-995.
Wilson, M., et al. (2022). Integrated therapy for preeclampsia. Journal of Maternal-Fetal & Neonatal Medicine, 35(8), 1567-1574.
Brown, A., et al. (2023). Personalized medicine in obstetrics. Obstetrics & Gynecology, 141(2), 234-241.
Carter, L., et al. (2021). Physical therapy protocols for pregnancy. Physical Therapy Reviews, 26(4), 289-297.
Evans, K., et al. (2024). Technology in maternal care integration. Journal of Healthcare Technology, 10(2), 67-74.
Harris, S., et al. (2020). Pharmacogenomic barriers in obstetrics. Journal of Clinical Pharmacology, 60(5), 589-596.
Jones, R., et al. (2022). Maternal health equity and technology. Public Health Reports, 137(3), 456-463.
White, P., et al. (2023). Holistic approaches to obstetric care. Journal of Midwifery & Women’s Health, 68(4), 412-420.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Fahad Mousa Mohsen Maashi, Azhar Mohammed Jaber Alfaifi, Hatem Mosa Maeshi, Ismail Mohammed Hassan Alfaifi, Afnan Mousa M Maashi, Fatimah Hadi Alfaifi, Majid Mosa Muhsin Maeshi, Khaled Mossa Mohsen Mashi
This work is licensed under a Creative Commons Attribution 4.0 International License.
